SLS ($SLS) Insider Trading & Smart Money Activity

SLS · Biotechnology · Latest filing Jun 16, 2026

$SLS has 1 insider trade on file. Insiders filed 1 Form 4 transaction in the last 12 months, none of them open-market purchases or sales.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
0
Net insider $ (12 mo)
$0
Congress trades (12 mo)
0
13F moves on file
0
Analyst ratings on file
0

SLS insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 0 0 0 / 0 0 / 0
Q3 2026 0 0 0 / 0 0 / 0
Q4 2026 0 0 0 / 0 0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All SLS insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
Insider Angelos StergiouPresident and CEO Buy (Grant or award) 1.06M sh —

1W / 1M / 6M = how SLS moved from the trade or filing date.

Insider trading in SLS: who is buying and selling

InsiderRoleTradesOpen-market netShares heldLast trade
Angelos Stergiou President and CEO 1 — Jun 16, 2026

Frequently asked questions

What is the latest insider trade in SLS?

Angelos Stergiou, President and CEO filed a buy (grant or award) of 1.06M sh on Jun 16, 2026.

Other biotechnology stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text